ASHPOfficial

MCM 2022: ASHP 2022 National Survey: Pharmacist Workforce Trends

In this episode, speakers from the 2022 Midyear Clinical Meeting review the state of the Pharmacy Technician Workforce based on data from the 2022 ASHP National Survey. 

 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hot Topics in Pharmacy: ASHP Advantage: Are There PROS of PRObiotics over Other Microbiome Restoration Products for C. difficile Infections?

Join our experts as they discuss the role of probiotics in Clostridioides difficile infection (CDI), review the differences between traditional fecal microbiota transplant and emerging live biotherapeutic products (LBP), and summarize the expanded indications and safety profiles of LBP pipeline drugs.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hot Topics in Pharmacy: Pharmacogenomics Considerations for Mental Health Disorders

Pharmacogenomics have started to become an increasingly important facet for the selection of therapies and treatment of mental health. In this episode, our content matter experts discuss pharmacogenomic testing, access, resources and education surrounding this evolving area of practice. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Advocating for Impact: DSCSA Update

This podcast will provide members a refresher on the current implementation status of the Drug Supply Chain Security Act, otherwise known as track and trace.  We’ll get recommendations from two leading experts on preparing for full DSCSA implementation in November 2023 and talk about what to expect as we approach that date.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Considerations for Conducting a Medication Use Evaluation of Andexanet Alfa for Reversal of Life-Threating Bleeding

Learn from experts in the field as they discuss barriers and key strategies for developing and conducting a medication-use evaluation (MUE) for the direct oral anticoagulant reversal agent, andexanet alfa. In addition to sharing the process for building a meaningful MUE, presenters will provide insights into navigating medication use evaluations with clinical controversy and local considerations.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Therapeutic Thursdays: Treatment of vaccine-preventable diseases – Rabies (C.E.)

Rabies is a rare and fatal condition that is not commonly seen in developed countries, though numerous cases are reported annually. In this episode, we will discuss a patient case and evaluate the pathophysiology, clinical presentation, and disease management of rabies.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

AJHP Voices: ASHP National Survey of Pharmacy Practice in Hospital Settings: Workforce — 2022

In this podcast, Dr. Craig Pedersen and Dr. Michael Ganio discuss the AJHP Practice Research Report, “ASHP National Survey of Pharmacy Practice in Hospital Settings: Workforce — 2022,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hot Topics: Pharmacy Services in Indigenous and Tribal Facilities

In this podcast we briefly highlight some aspects of pharmacy services in tribal and indigenous settings. The speakers here describe their experiences and answer some questions about this unique area of service. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Therapeutics Thursday (SCSS): Out of this World: Hemgenix® (etranacogene dezaparvovec), the Recently Approved Gene Therapy for Hemophilia B and the Most Expensive Drug in the World!

Hemophilia B, also known as factor IX deficiency, is the second most common type of hemophilia. This podcast will discuss the limitations of current therapeutic options for Hemophilia B and explore the use of the new gene therapy, Hemgenix® (etranacogene dezaprarvovec), the most expensive drug in the world, from both a clinical and cost perspective.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Therapeutic Thursdays: MCM 2022: Acute Care vs Ambulatory Focused Stewardship

In this episode from the 2022 Midyear Clinical Meeting, our content matter experts will discuss key considerations regarding the prescription of OPAT or COpAT in the persons who inject drugs (PWID) population.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.